Skip to main content
Erschienen in: Gastric Cancer 4/2017

01.07.2017 | Original Article

Examining the gastric cancer survival gap between Asians and whites in the United States

verfasst von: Hongbin Jin, Paulo S. Pinheiro, Karen E. Callahan, Sean F. Altekruse

Erschienen in: Gastric Cancer | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Globally, Asian countries bear a disproportionate gastric cancer burden. Asian Americans, the fastest growing minority population in the US, have higher gastric cancer survival than non-Hispanic whites (NHWs) despite higher incidence. Benefitting from uniform cancer registry standards within the US, we examine for the first time the heterogeneity in the Asian American population, which may elucidate the causes of these disparities.

Methods

SEER gastric cancer data from 2000 to 2012 were used to calculate 5-year survival estimates for NHWs and the six largest Asian ethnicities. Multivariate analyses were performed to identify critical prognostic factors and survival disparities between Asian groups and NHWs.

Results

We analyzed 33,313 NHW and 8473 Asian gastric cancer cases. All Asian groups had significantly higher 5-year survival than NHWs, at 29.8%. Among Asians, Koreans and Vietnamese had the highest and lowest survival, at 45.4% and 35.7%, respectively. The Korean survival advantage was largely attributable to relatively high proportions of localized stage and low proportions of cardia tumors. After adjusting for major prognostic factors, the survival disadvantage of NHWs, while attenuated, remained significant in comparison to all Asian groups (HR: 1.33, 95% CI: 1.24–1.43; reference: Korean). The survival disparities within the Asian groups vanished with adjustment.

Conclusions

This study characterizes distinctive gastric cancer survival patterns among the six major Asian groups and NHWs in the US. The favorable survival for Koreans is largely attributable to specific clinical factors, particularly stage at diagnosis. The causes of the survival disadvantage for NHWs remain elusive.
Literatur
5.
Zurück zum Zitat Gomez SL, Noone AM, Lichtensztajn DY, Scoppa S, Gibson JT, Liu L, et al. Cancer incidence trends among Asian American populations in the United States, 1990–2008. J Natl Cancer Inst. 2013;. doi:10.1093/jnci/djt157. Gomez SL, Noone AM, Lichtensztajn DY, Scoppa S, Gibson JT, Liu L, et al. Cancer incidence trends among Asian American populations in the United States, 1990–2008. J Natl Cancer Inst. 2013;. doi:10.​1093/​jnci/​djt157.
6.
Zurück zum Zitat Wang J, Sun Y, Bertagnolli MM. Comparison of gastric cancer survival between Caucasian and Asian patients treated in the United States: results from the surveillance epidemiology and end results (SEER) database. Ann Surg Oncol. 2015;. doi:10.1245/s10434-015-4388-4. Wang J, Sun Y, Bertagnolli MM. Comparison of gastric cancer survival between Caucasian and Asian patients treated in the United States: results from the surveillance epidemiology and end results (SEER) database. Ann Surg Oncol. 2015;. doi:10.​1245/​s10434-015-4388-4.
7.
Zurück zum Zitat Bonenkamp JJ, van de Velde CJ, Kampschöer GH, Hermans J, Hermanek P, Bemelmans M, et al. Comparison of factors influencing the prognosis of Japanese, German, and Dutch gastric cancer patients. World J Surg. 1993;17:410–4.CrossRefPubMed Bonenkamp JJ, van de Velde CJ, Kampschöer GH, Hermans J, Hermanek P, Bemelmans M, et al. Comparison of factors influencing the prognosis of Japanese, German, and Dutch gastric cancer patients. World J Surg. 1993;17:410–4.CrossRefPubMed
8.
Zurück zum Zitat Strong VE, Song KY, Park CH, Jacks LM, Gonen M, Shah M, et al. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg. 2010;. doi:10.1097/SLA.0b013e3181d3d29b.PubMed Strong VE, Song KY, Park CH, Jacks LM, Gonen M, Shah M, et al. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg. 2010;. doi:10.​1097/​SLA.​0b013e3181d3d29b​.PubMed
9.
Zurück zum Zitat Davis PA, Sano T. The difference in gastric cancer between Japan, USA and Europe: what are the facts? What are the suggestions? Crit Rev Oncol Hematol. 2001;40:77–94.CrossRefPubMed Davis PA, Sano T. The difference in gastric cancer between Japan, USA and Europe: what are the facts? What are the suggestions? Crit Rev Oncol Hematol. 2001;40:77–94.CrossRefPubMed
10.
Zurück zum Zitat Theuer CP, Kurosaki T, Ziogas A, Butler J, Anton-Culver H. Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates. Cancer. 2000;9:1883–92.CrossRef Theuer CP, Kurosaki T, Ziogas A, Butler J, Anton-Culver H. Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates. Cancer. 2000;9:1883–92.CrossRef
11.
Zurück zum Zitat Nelson R, Ko EB, Arrington A, Lee W, Kim J, Garcia-Aguilar J, et al. Race and correlations between lymph node number and survival for patients with gastric cancer. J Gastrointest Surg. 2013;. doi:10.1007/s11605-012-2125-x.PubMed Nelson R, Ko EB, Arrington A, Lee W, Kim J, Garcia-Aguilar J, et al. Race and correlations between lymph node number and survival for patients with gastric cancer. J Gastrointest Surg. 2013;. doi:10.​1007/​s11605-012-2125-x.PubMed
12.
Zurück zum Zitat Howard JH, Hiles JM, Leung AM, Stern SL, Bilchik AJ. Race influences stage-specific survival in gastric cancer. Am Surg. 2015;81:259–67.PubMed Howard JH, Hiles JM, Leung AM, Stern SL, Bilchik AJ. Race influences stage-specific survival in gastric cancer. Am Surg. 2015;81:259–67.PubMed
13.
Zurück zum Zitat Theuer CP. Asian gastric cancer patients at a southern California comprehensive cancer center are diagnosed with less advanced disease and have superior stage-stratified survival. Am Surg. 2000;66:821–6.PubMed Theuer CP. Asian gastric cancer patients at a southern California comprehensive cancer center are diagnosed with less advanced disease and have superior stage-stratified survival. Am Surg. 2000;66:821–6.PubMed
14.
Zurück zum Zitat Gill S, Shah A, Le N, Cook EF, Yoshida EM. Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a Canadian cancer center. J Clin Oncol. 2003;21:2070–6.CrossRefPubMed Gill S, Shah A, Le N, Cook EF, Yoshida EM. Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a Canadian cancer center. J Clin Oncol. 2003;21:2070–6.CrossRefPubMed
15.
Zurück zum Zitat Kim J, Sun CL, Mailey B, Prendergast C, Artinyan A, Bhatia S, et al. Race and ethnicity correlate with survival in patients with gastric adenocarcinoma. Ann Oncol. 2010;. doi:10.1093/annonc/mdp290. Kim J, Sun CL, Mailey B, Prendergast C, Artinyan A, Bhatia S, et al. Race and ethnicity correlate with survival in patients with gastric adenocarcinoma. Ann Oncol. 2010;. doi:10.​1093/​annonc/​mdp290.
17.
Zurück zum Zitat Schwarz RE, Zagala-Nevarez K. Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease location and individual patient comorbidity. Eur J Surg Oncol. 2002;28:214–9.CrossRefPubMed Schwarz RE, Zagala-Nevarez K. Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease location and individual patient comorbidity. Eur J Surg Oncol. 2002;28:214–9.CrossRefPubMed
18.
Zurück zum Zitat Kim J, Mailey B, Senthil M, Artinyan A, Sun CL, Bhatia S. Disparities in gastric cancer outcomes among Asian ethnicities in the USA. Ann Surg Oncol. 2009;. doi:10.1245/s10434-009-0584-4. Kim J, Mailey B, Senthil M, Artinyan A, Sun CL, Bhatia S. Disparities in gastric cancer outcomes among Asian ethnicities in the USA. Ann Surg Oncol. 2009;. doi:10.​1245/​s10434-009-0584-4.
20.
Zurück zum Zitat Gomez SL, Glaser SL, Horn-Ross PL, Cheng I, Quach T, Clarke CA, et al. Cancer research in Asian American, Native Hawaiian, and Pacific Islander populations: accelerating cancer knowledge by acknowledging and leveraging heterogeneity. Cancer Epidemiol Biomark Prev. 2014;. doi:10.1158/1055-9965.EPI-14-0624. Gomez SL, Glaser SL, Horn-Ross PL, Cheng I, Quach T, Clarke CA, et al. Cancer research in Asian American, Native Hawaiian, and Pacific Islander populations: accelerating cancer knowledge by acknowledging and leveraging heterogeneity. Cancer Epidemiol Biomark Prev. 2014;. doi:10.​1158/​1055-9965.​EPI-14-0624.
24.
Zurück zum Zitat Hsieh MC, Pareti LA, Chen VW. Using NAPIIA to improve the accuracy of Asian race codes in registry data. J Registry Manag. 2011;38:190–5.PubMed Hsieh MC, Pareti LA, Chen VW. Using NAPIIA to improve the accuracy of Asian race codes in registry data. J Registry Manag. 2011;38:190–5.PubMed
25.
Zurück zum Zitat Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer. 2004;40:2307–16.CrossRefPubMed Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer. 2004;40:2307–16.CrossRefPubMed
26.
Zurück zum Zitat Yu M, Tatalovich Z, Gibson JT, Cronin KA. Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry data. Cancer Causes Control. 2014;. doi:10.1007/s10552-013-0310-1.PubMed Yu M, Tatalovich Z, Gibson JT, Cronin KA. Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry data. Cancer Causes Control. 2014;. doi:10.​1007/​s10552-013-0310-1.PubMed
27.
Zurück zum Zitat Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.PubMed Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.PubMed
28.
Zurück zum Zitat Pinheiro PS, van der Heijden LH, Coebergh JW. Unchanged survival of gastric cancer in the southeastern Netherlands since 1982: result of differential trends in incidence according to Lauran type and subsite. Int J Cancer. 1999;84:28–32.CrossRefPubMed Pinheiro PS, van der Heijden LH, Coebergh JW. Unchanged survival of gastric cancer in the southeastern Netherlands since 1982: result of differential trends in incidence according to Lauran type and subsite. Int J Cancer. 1999;84:28–32.CrossRefPubMed
31.
Zurück zum Zitat Kim BJ, Heo C, Kim BK, Kim JY, Kim JG. Effectiveness of gastric cancer screening programs in South Korea: organized vs opportunistic models. World J Gastroenterol. 2013;. doi:10.3748/wjg.v19.i5.736. Kim BJ, Heo C, Kim BK, Kim JY, Kim JG. Effectiveness of gastric cancer screening programs in South Korea: organized vs opportunistic models. World J Gastroenterol. 2013;. doi:10.​3748/​wjg.​v19.​i5.​736.
32.
Zurück zum Zitat Dan YY, So JB, Yeoh KG. Endoscopic screening for gastric cancer. Clin Gastroenterol Hepatol. 2006;4:709–16.CrossRefPubMed Dan YY, So JB, Yeoh KG. Endoscopic screening for gastric cancer. Clin Gastroenterol Hepatol. 2006;4:709–16.CrossRefPubMed
33.
Zurück zum Zitat Yeh JM, Hur C, Ward Z, Schrag D, Goldie SJ. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis. Gut. 2016;. doi:10.1136/gutjnl-2014-308588.PubMed Yeh JM, Hur C, Ward Z, Schrag D, Goldie SJ. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis. Gut. 2016;. doi:10.​1136/​gutjnl-2014-308588.PubMed
35.
Zurück zum Zitat Mizoue T, Yoshimura T, Tokui N, Hoshiyama Y, Yatsuya H, Sakata K, et al. Prospective study of screening for stomach cancer in Japan. Int J Cancer. 2003;106:103–7.CrossRefPubMed Mizoue T, Yoshimura T, Tokui N, Hoshiyama Y, Yatsuya H, Sakata K, et al. Prospective study of screening for stomach cancer in Japan. Int J Cancer. 2003;106:103–7.CrossRefPubMed
42.
Zurück zum Zitat Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H. Surgical treatment for gastric cancer: the Japanese approach. Semin Oncol. 1996;23:360–8.PubMed Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H. Surgical treatment for gastric cancer: the Japanese approach. Semin Oncol. 1996;23:360–8.PubMed
43.
Zurück zum Zitat Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomark Prev. 2014;. doi:10.1158/1055-9965.EPI-13-1057. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomark Prev. 2014;. doi:10.​1158/​1055-9965.​EPI-13-1057.
44.
Zurück zum Zitat Kamangar F, Sheikhattari P, Mohebtash M. Helicobacter pylori and its effects on human health and disease. Arch Iran Med. 2011. doi: 011143/AIM.0010. Kamangar F, Sheikhattari P, Mohebtash M. Helicobacter pylori and its effects on human health and disease. Arch Iran Med. 2011. doi: 011143/AIM.0010.
45.
Zurück zum Zitat Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–31.CrossRefPubMed Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–31.CrossRefPubMed
46.
Zurück zum Zitat Derakhshan MH, Malekzadeh R, Watabe H, Yazdanbod A, Fyfe V, Kazemi A, et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut. 2008;57:298–305.CrossRefPubMed Derakhshan MH, Malekzadeh R, Watabe H, Yazdanbod A, Fyfe V, Kazemi A, et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut. 2008;57:298–305.CrossRefPubMed
48.
Zurück zum Zitat Razum O. Commentary: of salmon and time travelers—musing on the mystery of migrant mortality. Int J Epidemiol. 2006;35:919–21.CrossRefPubMed Razum O. Commentary: of salmon and time travelers—musing on the mystery of migrant mortality. Int J Epidemiol. 2006;35:919–21.CrossRefPubMed
50.
Zurück zum Zitat Tendulkar SA, Hamilton RC, Chu C, Arsenault L, Duffy K, Huynh V, et al. Investigating the myth of the “model minority”: a participatory community health assessment of Chinese and Vietnamese adults. J Immigr Minor Health. 2012;. doi:10.1007/s10903-011-9517-y.PubMed Tendulkar SA, Hamilton RC, Chu C, Arsenault L, Duffy K, Huynh V, et al. Investigating the myth of the “model minority”: a participatory community health assessment of Chinese and Vietnamese adults. J Immigr Minor Health. 2012;. doi:10.​1007/​s10903-011-9517-y.PubMed
52.
Zurück zum Zitat Hwang H. Colorectal cancer screening among Asian Americans. Asian Pac J Cancer Prev. 2013;14:4025–32.CrossRefPubMed Hwang H. Colorectal cancer screening among Asian Americans. Asian Pac J Cancer Prev. 2013;14:4025–32.CrossRefPubMed
Metadaten
Titel
Examining the gastric cancer survival gap between Asians and whites in the United States
verfasst von
Hongbin Jin
Paulo S. Pinheiro
Karen E. Callahan
Sean F. Altekruse
Publikationsdatum
01.07.2017
Verlag
Springer Japan
Erschienen in
Gastric Cancer / Ausgabe 4/2017
Print ISSN: 1436-3291
Elektronische ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-016-0667-4

Weitere Artikel der Ausgabe 4/2017

Gastric Cancer 4/2017 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.